Imaging drug imaging drug pafolacianine was approved by the FDA to detect ovarian cancer lesions in patients during surgery.
Men with localized prostate cancer were most likely to select treatment with radiotherapy over surgery and its associated adverse effects.
Late-stage cancer and poor outcomes for patients may occur as a result of low screening numbers during the COVID-19 pandemic.
Breast cancer survivors who are minorities or medically underserved appear to experience a benefit in health-related quality of life after taking part in a community-based physical activity program.
As the year 2021 comes to a close, CancerNetwork® reviews ongoing clinical research and upcoming innovations in the non–small cell lung cancer space.
Don Dizon, MD, FACP, FASCO, discusses the need to improve treatment strategies for transgender patients with cancer.
Early expansion of Medicaid may lead to a reduction in cancer mortality.
One in 3 nurses do not feel emotionally health, a large number of whom have experienced trauma due to the COVID-19 pandemic and no longer wish to be in their job position.
Aparna Parikh, MD, MS, discusses how her early experiences with physical fitness shaped her current relationship with exercise.
Investigators have identified a gap in end-of-life care among patients with cancer who are dual eligible for Medicare and Medicaid.